CLINICAL_TRIALS
trial_result
· 2024-07-26
Clinical Trial Update: Evaluation of the Hypoglycaemia Notification Device Hyposafe H02 [NA]
Summary
The study evaluating the Hyposafe H02 hypoglycemia notification device in type 1 diabetes has been terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UNEEG Medical A/S | Conditions: Diabetes Mellitus, Type 1 | NA | Status: TERMINATED | Results posted: 2024-07-26